Made for the UK. Informed by evidence.Our editorial promise
INTERNATIONAL CONTEXT FOR UK READERS

Obesity care in South America

Brazil and Chile offer UK readers two examples of how medicine approval, public provision and pharmacy regulation fit together. These country pages provide editorial context, not routes to obtaining treatment abroad. They do not describe every South American health system or establish access through the UK NHS.

An announcement is not a funded pathway

Brazil's work on possible SUS incorporation is a useful example: a research programme or assessment request does not itself give every eligible patient access to free medicine. Look for the final decision and the service that delivers it.

Read the national evidence

Anvisa and Chile's ISP publish information about prescription controls and unlawful products. Their work helps explain the local market, but UK decisions should rely on MHRA information, the relevant NHS pathway and registered UK healthcare professionals.

Explore the country guides

2 guides

Brazil ↗

Brazil's GLP-1 landscape is changing through new authorisations and work on possible SUS provision. Regulatory progress should not be confused with a fully implemented public treatment pathway or a guaranteed pharmacy price.

Read the country guide →

Chile ↗

Chile's ISP provides product information for authorised medicines and a separate route for checking pharmacies permitted to sell online. Both are useful when comparing treatment offers, but neither establishes insurance payment.

Read the country guide →